Add Company
Join Now

Acrux Revenue and Competitors

License our Company Data API

Melbourne,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Acrux's estimated annual revenue is currently $20.5M per year.(i)
  • Acrux's estimated revenue per employee is $201,000

Employee Data

  • Acrux has 102 Employees.(i)
  • Acrux grew their employee count by 24% last year.

Acrux's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CFO / Company SecretaryReveal Email/Phone
3
Portfolio DirectorReveal Email/Phone
4
Product Development & Technical Affairs DirectorReveal Email/Phone
5
Technical & Project DirectorReveal Email/Phone
6
Senior Project ManagerReveal Email/Phone
7
Analytical Development ManagerReveal Email/Phone
8
HR & Facilities ManagerReveal Email/Phone
9
Regulatory Affairs ManagerReveal Email/Phone
10
Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Acrux?

Acrux (ASX: ACR) is a pharmaceutical company dedicated to developing and commercialising specialty and generic topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised through licensees a number of pharmaceutical products in the US and Europe using the Patchless PatchTM, a fast-drying and invisible topical application technology. Marketed products include Axiron®, Evamist® and Lenzetto®. More recently, in addition to specialty products, Acrux has identified and initiated development of a range of generic products. Acrux is leveraging its on-site laboratories, GMP manufacturing suite, clinical and commercial experience to bring more products to market. Acrux encourages collaboration and is well positioned to discuss partnering and product development.

keywords:N/A

N/A

Total Funding

102

Number of Employees

$20.5M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Acrux News

2022-04-20 - Topical Drug Delivery Market Size by Region 2022-2030 ...

Tapemark, Acrux Limited Nitto Denko Corporation Skinvisible Pharmaceuticals, Inc. Mylan Pharmaceuticals Inc. Pocono Coated Products LLC

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.6M10210%N/A
#2
$25.1M102-3%N/A
#3
$25M1027%N/A
#4
$29.9M10327%N/A
#5
$27.8M10314%N/A